Human Immunodeficiency Virus (HIV) Clinical Trials in Kisumu
3 recruitingKisumu, Kenya
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,390 enrolled81 locationsNCT07044297
Recruiting
Phase 3
A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,580 enrolled30 locationsNCT07071623
Recruiting
Not Applicable
HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
University of Washington30,000 enrolled1 locationNCT07089966